✦ LIBER ✦

Management of Italian Patients With Advanced Non–Small-Cell Lung Cancer After Second-Line Treatment: Results of the Longitudinal Phase of the LIFE Observational Study

✍ Scribed by de Marinis, Filippo; Ardizzoni, Andrea; Fontanini, Gabriella; Grossi, Francesco; Cappuzzo, Federico; Novello, Silvia; Santo, Antonio; Lorusso, Vito; Cortinovis, Diego; Iurlaro, Monica; Galetta, Domenico; Gridelli, Cesare

Book ID: 122233976
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 420 KB
Volume: 15
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2014.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advanced non-small cell lung cancer mana

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

✍ Gridelli, Cesare; de Marinis, Filippo; Ardizzoni, Andrea; Novello, Silvia; Fonta 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 345 KB

Phase II study of weekly paclitaxel as s

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

✍ Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Single agent gemcitabine in the second-l

Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens

✍ Ugur Coskun; Ali Osman Kaya; Süleyman Buyukberber; Mustafa Benekli; Aytug Uner; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 147 KB

The favorable prognostic significance of

The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: Results of a prospective observational study

✍ Dediu, Mircea; Crisan, Emilia; Radut, Maria; Tarlea, Alin; Median, Dragos; Alexa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Phase II study of docetaxel (DOC) and ca

Phase II study of docetaxel (DOC) and carboplatin (CP) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase II study with paclitaxel for the t

Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer

✍ Gatzemeier, Ulrich; Heckmayr, Marlene; Neuhauss, Renate; Schlüter, Ingrid; Pawel 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 305 KB